Disrupt Health invests in DiaMonTech’s non-invasive glucose monitoring tech

Q: How long will it take to read this news story?

The story "Disrupt Health invests in DiaMonTech’s non-invasive glucose monitoring tech" has 266 words across 11 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Disrupt Health invests in DiaMonTech’s non-invasive glucose monitoring tech" was covered 5 days ago by e27, a news publisher based in Singapore.

Q: How trustworthy is 'e27' news outlet?

e27 is a fully independent (privately-owned) news outlet established in 2006 that covers mostly startups and technology news. The outlet is headquartered in Singapore and publishes an average of 8 news stories per day. It's most recent story was published 9 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23621656</li><li>URL: https://beamstart.com/news/disrupt-health-invests-in-diamontechs-173179966158</li></ul>

e27 Logo e27 5d ago

Disrupt Health invests in DiaMonTech’s non-invasive glucose monitoring tech - e27

Quick Summary:

Disrupt Health Impact Fund, a Thailand-based venture capital fund focused on healthcare innovation, has announced its first investment in DiaMonTech, a German deeptech startup specializing in non-invasive glucose monitoring.

The fund will provide DiaMonTech connections with healthcare experts in the public and private sectors across Southeast Asia and facilitate its entry into the region.

This empowers individuals to take control of their diabetes management and make more informed decisions about their health.